Curriculum Guidelines & Regulatory Criteria for Family Nurse Practitioners Seeking Prescriptive Authority To Manage Pharmacotherapeutics in Primary Care. Summary Report 1998.

Institution	National Council of State Boards of Nursing, Chicago, IL.; National Organization of Nurse Practitioner Faculties, Washington, DC.
Titel	Curriculum Guidelines & Regulatory Criteria for Family Nurse Practitioners Seeking Prescriptive Authority To Manage Pharmacotherapeutics in Primary Care. Summary Report 1998.
Quelle	(1998), (62 Seiten) PDF als Volltext kostenfreie Datei Verfügbarkeit
Sprache	englisch
Dokumenttyp	gedruckt; online; Monographie
Schlagwörter	Advisory Committees; Agency Role; Competence; Curriculum Development; Educational Needs; Evaluation Criteria; Federal Legislation; Federal Regulation; Guidelines; Higher Education; Integrated Curriculum; National Organizations; National Standards; Nurses; Nursing Education; Pharmacology; Professional Continuing Education; Public Agencies; Public Policy; Student Certification; Student Evaluation + Suchen Sie Ihr Suchwort? Beratungsstelle; Kompetenz; Curriculum; Development; Curriculumentwicklung; Lehrplan; Entwicklung; Educational need; Bildungsbedarf; Bundesrecht; Bundeskompetenz; Richtlinien; Hochschulbildung; Hochschulsystem; Hochschulwesen; Pflegepädagogik; Arzneikunde; Berufsfeldbezogener Unterricht; Weiterbildung; Öffentliche Einrichtung; Öffentliche Ordnung; Schulzeugnis; Schulnote; Studentische Bewertung
Abstract	This report describes a multi-organizational project to accomplish two goals: (1) to develop pharmacology/pharmacotherapeutics curriculum guidelines designed to prepare family nurse practitioners (FNPs) for full prescriptive authority; and (2) to develop regulatory criteria for evaluating the academic preparation and clinical competencies of FNPs applying for prescriptive authority. Section 1 provides background information on the project and profiles the project's 11-member advisory committee, which includes experts from nursing education, practice, and regulatory arenas. Section 2 outlines the process of development of the model pharmacology/pharmacotherapeutics curriculum guidelines. Section 3 is an overview of the current regulatory environment and development of the regulatory evaluation criteria that details legal recognition of FNPs in individual states and territories. Section 4 recaps the guidelines' objectives, development, and planned dissemination. The following materials are included in the report's eight appendixes: (1) lists of project staff, National Council of State Boards of Nursing advisory committee members, other contributors, and National Organization of Nurse Practitioner Faculties expert panel members; (2) model pharmacology/pharmacotherapeutics curriculum guidelines; (3) recommended regulatory criteria for evaluating family nurse practitioners desiring prescriptive authority; (4) examples of substances in schedules I-V; and (5) a list of organizations, groups, and individuals who provided comments on draft documents. (Contains 12 references.) (MN)
Erfasst von	ERIC (Education Resources Information Center), Washington, DC